tradingkey.logo

GeneDx Holdings Corp

WGS
136.910USD
+5.410+4.11%
Fechamento 10/31, 16:00ETCotações atrasadas em 15 min
3.96BValor de mercado
1898.84P/L TTM

GeneDx Holdings Corp

136.910
+5.410+4.11%

Mais detalhes de GeneDx Holdings Corp Empresa

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.

Informações de GeneDx Holdings Corp

Código da empresaWGS
Nome da EmpresaGeneDx Holdings Corp
Data de listagemSep 04, 2020
CEOMs. Katherine A. Stueland
Número de funcionários1000
Tipo de títulosOrdinary Share
Fim do ano fiscalSep 04
Endereço333 Ludlow Street
CidadeSTAMFORD
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal06902
Telefone18887291206
Sitehttps://sema4.com/
Código da empresaWGS
Data de listagemSep 04, 2020
CEOMs. Katherine A. Stueland

Executivos da empresa GeneDx Holdings Corp

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
3.75K
-8.86%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Katherine A. Stueland
Ms. Katherine A. Stueland
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Jason Michael Ryan, CPA
Mr. Jason Michael Ryan, CPA
Chairman of the Board
Chairman of the Board
--
--
Mr. Eli D. Casdin
Mr. Eli D. Casdin
Independent Director
Independent Director
--
--
Mr. Richard C. (Rick) Pfenniger, Jr.
Mr. Richard C. (Rick) Pfenniger, Jr.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Joshua Ruch
Mr. Joshua Ruch
Independent Director
Independent Director
223.99K
+6.12%
Dr. Emily M. Leproust, Ph.D.
Dr. Emily M. Leproust, Ph.D.
Independent Director
Independent Director
33.16K
+63.87%
Mr. Kevin Feeley
Mr. Kevin Feeley
Chief Financial Officer
Chief Financial Officer
3.75K
-8.86%
Mr. Keith A. Meister
Mr. Keith A. Meister
Independent Director
Independent Director
3.58K
-82.23%
Dr. Thomas Fuchs
Dr. Thomas Fuchs
Director
Director
--
--
Dr. Bryan Dechairo
Dr. Bryan Dechairo
Chief Operating Officer
Chief Operating Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Patients with third party insurance
81.10M
78.98%
Institutional customers
18.38M
17.90%
Other
2.87M
2.79%
Self pay patients
339.00K
0.33%

Distribuição de ações

Atualizado em: sex, 31 de out
Atualizado em: sex, 31 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
William Blair Investment Management, LLC
5.64%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
Outro
63.74%
Investidores
Investidores
Proporção
Corvex Management LP
10.58%
Casdin Capital, LLC
10.54%
William Blair Investment Management, LLC
5.64%
Icahn School of Medicine at Mount Sinai
4.75%
OPKO Health Inc
4.74%
Outro
63.74%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
36.63%
Hedge Fund
36.17%
Investment Advisor
31.04%
Corporation
10.65%
Research Firm
6.54%
Individual Investor
1.61%
Pension Fund
0.81%
Venture Capital
0.54%
Bank and Trust
0.48%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
427
31.75M
110.52%
-296.44K
2025Q2
397
34.23M
119.24%
+1.02M
2025Q1
398
32.79M
115.46%
-47.86K
2024Q4
341
29.17M
104.22%
+1.72M
2024Q3
289
26.18M
97.50%
+377.48K
2024Q2
262
24.98M
95.33%
+588.25K
2024Q1
260
22.13M
86.19%
+1.41M
2023Q4
271
20.57M
80.67%
-567.28K
2023Q3
283
21.68M
85.29%
-751.02K
2023Q2
291
21.85M
86.03%
-864.88K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Corvex Management LP
3.06M
10.65%
--
--
Aug 22, 2025
Casdin Capital, LLC
3.05M
10.6%
-461.51K
-13.16%
Aug 22, 2025
William Blair Investment Management, LLC
1.63M
5.68%
+442.41K
+37.21%
Jun 30, 2025
Icahn School of Medicine at Mount Sinai
1.37M
4.78%
-1.35M
-49.50%
Feb 21, 2025
OPKO Health Inc
1.37M
4.77%
-800.83K
-36.88%
Nov 20, 2024
BlackRock Institutional Trust Company, N.A.
1.28M
4.45%
+241.28K
+23.25%
Jun 30, 2025
Pentwater Capital Management LP
1.22M
4.25%
+1.19M
+3712.50%
Jun 30, 2025
The Vanguard Group, Inc.
1.18M
4.09%
+148.96K
+14.50%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
1.04M
3.61%
+533.38K
+105.89%
Jun 30, 2025
UBS Financial Services, Inc.
1.00M
3.49%
+951.52K
+1895.62%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: seg, 6 de out
Atualizado em: seg, 6 de out
Nome
Proporção
Global X Genomics & Biotechnology ETF
3.85%
SPDR S&P Health Care Services ETF
3.59%
Innovator IBD 50 Fund ETF
3.05%
Alger Mid Cap 40 ETF
2.05%
Harbor Health Care ETF
2.05%
Simplify Health Care ETF
1.32%
Franklin Genomic Advancements ETF
1.23%
Main Thematic Innovation ETF
1.02%
Hypatia Women CEO ETF
0.87%
ARK Genomic Revolution ETF
0.83%
Ver Mais
Global X Genomics & Biotechnology ETF
Proporção3.85%
SPDR S&P Health Care Services ETF
Proporção3.59%
Innovator IBD 50 Fund ETF
Proporção3.05%
Alger Mid Cap 40 ETF
Proporção2.05%
Harbor Health Care ETF
Proporção2.05%
Simplify Health Care ETF
Proporção1.32%
Franklin Genomic Advancements ETF
Proporção1.23%
Main Thematic Innovation ETF
Proporção1.02%
Hypatia Women CEO ETF
Proporção0.87%
ARK Genomic Revolution ETF
Proporção0.83%

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Data
Tipo
Proporção
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
Apr 28, 2023
Merger
33→1
KeyAI